Indegene Reports 32.8% YoY Growth in Q4FY26, Crosses ₹1,000 Crore Quarterly Revenue

Indegene, the strategic operating partner to the global life sciences industry, reported its financial results for Q4 and the full year ended March 31, 2026.

Q4 FY26 Highlights

- Revenue of INR 10,034 Mn (USD 109.7 Mn), up 32.8% YoY in INR (25.6% YoY in USD) & 6.5% QoQ
- Adjusted EBITDA of INR 1,889 Mn at 18.8% margin, up 23.2% YoY & 5.4% QoQ
- Strong bookings quarter: 1 deal >$3M ACV and 7 deals in the $1-3M range

Full-Year FY26 Highlights

- Revenue of INR 35,105 Mn (USD 396.9 Mn), up 23.6% YoY in INR (18.2% in USD)
- Adjusted EBITDA of INR 6,793 Mn at 19.4% margin, up 20.8% YoY
- Cash flow from operations of INR 6,508 Mn, up 47.3% YoY, highlighting the strength of business and operating fundamentals
- Board has recommended a final dividend of INR 2.25 per equity share for FY26, up 12.5% YoY

"FY26 was a landmark year for Indegene. We surpassed ₹1,000 crore in quarterly revenue for the first time, and ₹3,500 crore for the full year", said Manish Gupta, Chairman and CEO, Indegene. "This reflects growing strategic depth in our largest client relationships, with 53 clients contributing over $1M in annual revenue, alongside breakthrough GenAI-led wins across Commercial and Medical. With a strong pipeline and an industry-leading revenue per employee of $75k, we will build on this momentum in FY27."

"FY26 reflected disciplined financial execution. Our cash conversion ratio of 162% reflects continued strong underlying cash generation, while higher non-cash charges impact the reported profits", said Suhas Prabhu, CFO, Indegene. "Reflecting this strength, the Board has recommended a final dividend of ₹2.25 per share - a 12.5% increase over FY25. With healthy margins, strong cash generation, and recent acquisitions now integrated, we enter FY27 with confidence."

Shares of Indegene Limited was last trading in BSE at Rs. 495.40 as compared to the previous close of Rs. 499.75. The total number of shares traded during the day was 8521 in over 1009 trades.

The stock hit an intraday high of Rs. 507.45 and intraday low of 491.90. The net turnover during the day was Rs. 4253906.00.

Source : Equity Bulls

Keywords

Indegene HealthcareResearch Analytics Technology INE065X01017 Q4FY26 FY2026 ResultUpdate